TNO155 |
| Catalog No.GC39514 |
TNO155 es un potente inhibidor alostérico selectivo y activo por vÍa oral de SHP2 de tipo salvaje (IC50 = 0,011 μ M). TNO155 tiene el potencial para el estudio de tumores malignos dependientes de RTK, especialmente tumores sÓlidos avanzados.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1801765-04-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
TNO155 is a potent selective and orally active allosteric inhibitor of wild-type SHP2 (IC50=0.011 µM). TNO155 has the potential for the study of RTK-dependent malignancies, especially advanced solid tumors[1].
[1]. TNO155: SHP2 inhibitor
Average Rating: 5 (Based on Reviews and 24 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *